Niowave
Niowave, founded in 2005 and based in Lansing, MI, specializes in manufacturing radioisotopes for medical and industrial applications using superconducting electron linear accelerators.
Company History
Niowave was founded in 2005. Since its establishment, the company has focused on manufacturing radioisotopes for both medical and industrial applications. The company's headquarters is located in Lansing, MI.
Isotope Production
Niowave produces radioisotopes utilizing superconducting electron linear accelerators. These devices enable efficient isotope production, which supports both medical and industrial use. The company is licensed by the Nuclear Regulatory Commission (NRC) to handle radioactive materials, including uranium. The production and distribution processes of isotopes leverage the existing radiopharmaceutical supply chain and comply with FDA approval protocols.
Radioisotope Applications
Niowave's radioisotopes are crucial for various applications. In the medical field, they are used for diagnostic imaging and therapeutic treatments. In the industrial sector, the isotopes serve roles in material analysis and other precision applications.
Radiochemistry Facility
Niowave operates an in-house radiochemistry facility. This facility is designed to extract and purify solid, liquid, and gaseous radioactive isotopes. The in-house capabilities ensure stringent quality control and efficient processing of radioisotopes.
Licenses and Compliance
Niowave holds a license from the Nuclear Regulatory Commission (NRC) to work with radioactive materials. This includes the authorization to handle uranium. The company's production processes conform to all regulatory requirements, ensuring safe and compliant operations.